v3.25.2
Commitments and Contingencies (Additional Information) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2013
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Commitments and Contingencies [Line Items]            
Royalty expenses   $ 100 $ 100 $ 100 $ 100  
Finance lease liabilities   $ 0   $ 0    
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]   Derivative Liability, Noncurrent   Derivative Liability, Noncurrent    
Lease Expense   $ 200 300 $ 500 500  
Additional ROU assets   1,868   1,868   $ 2,225
Corresponding lease liabilities   1,126   1,126   1,523
Implementation fee related to sales       72    
Implementation fee of First Year       1,200    
Implementation fee of Second And Third Year       1,300    
Former Employee [Member]            
Commitments and Contingencies [Line Items]            
Agreement settlement payment       3,500    
Former Employee One[Member]            
Commitments and Contingencies [Line Items]            
Agreement settlement payment       $ 2,500    
Probudur [Member]            
Commitments and Contingencies [Line Items]            
Percentage on net sale       6.00%    
Envelta [Member]            
Commitments and Contingencies [Line Items]            
Percentage on net sale       6.00%    
Epoladerm [Member]            
Commitments and Contingencies [Line Items]            
Percentage on net sale       6.00%    
Product Development Agreement [Member] | Developers [Member]            
Commitments and Contingencies [Line Items]            
Royalty expenses   1,600 2,400 $ 2,300 4,700  
Accrued royalty payables   4,500   4,500   $ 4,000
Agreement maturity date Oct. 02, 2028          
Agreement maturity renewal description The Product Development Agreement will renew automatically for subsequent successive one-year renewal periods unless Scilex Pharma or the Developers terminate it upon six-months’ written notice.          
Product Development Agreement [Member] | Developers [Member] | Minimum [Member]            
Commitments and Contingencies [Line Items]            
Royalty payment percentage related to future years 25.00%          
Product Development Agreement [Member] | Developers [Member] | Maximum [Member]            
Commitments and Contingencies [Line Items]            
Royalty payment percentage related to future years 35.00%          
Product Development Agreement [Member] | Scilex Pharma [Member]            
Commitments and Contingencies [Line Items]            
Royalty expenses   $ 600 $ 2,000 $ 1,900 $ 4,400  
Non-cancelable Lease Agreements [Member] | Minimum [Member] | Research and Development Facilities [Member]            
Commitments and Contingencies [Line Items]            
Operating lease, remaining lease term   2 years 3 months 18 days   2 years 3 months 18 days    
Operating lease, lease term   3 years   3 years    
Non-cancelable Lease Agreements [Member] | Maximum [Member] | Research and Development Facilities [Member]            
Commitments and Contingencies [Line Items]            
Operating lease, lease term   5 years   5 years